Inotiv, Inc. — Director's Dealing 2020

Dec 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2020-12-02

Reporting Person: Sagartz John E (Director, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-02	Common Shares	A	9653	—	Acquired	643885	Direct

Footnotes

F1: Represents a restricted grant, which vests in equal installments on the first and second anniversaries of the grant date, provided that the grantee is employed by the Company or is serving as a Non-Employee Director of the Company.